Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 1;3(12):a015495.
doi: 10.1101/cshperspect.a015495.

Lessons and limits of mouse models

Affiliations
Review

Lessons and limits of mouse models

Anita S Chong et al. Cold Spring Harb Perspect Med. .

Abstract

Seminal studies in rabbits and rodent transplantation models by Peter Medawar revealed that cellular processes, rather than humoral antibodies, are central to the acute rejection of transplanted organs, and much of basic transplantation research continues to be focused on the biology and control of these cells, which were subsequently shown to be T cells. However, the success of current immunosuppression at controlling T-cell-mediated rejection has resulted in an increasing awareness of antibody-mediated rejection in the clinic. This, in turn, has fueled an emerging interest in the biology of allospecific antibodies, the B cells that produce these antibodies, and the development of mouse models that allow their investigation. Here we summarize some of the more widely used mouse models that have been developed to study the immunobiology of alloreactivity, transplantation rejection and tolerance, and used to identify therapeutic strategies that modulate these events.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Skin transplantation: Technically simple, a good model for acute T-cell-mediated rejection, and considered a stringent model of tolerance. (B) Heterotopic heart transplantation: Moderate technical difficulty, a good model for acute T-cell-mediated rejection, can model acute and chronic antibody-mediated rejection, notable differences in the pathology of chronic rejection from human chronic rejection, and most common model to investigate immunological tolerance. (C) Orthotopic kidney transplantation: Technically difficult, can be a life-sustaining graft, and can model spontaneous graft acceptance and chronic rejection. (D) Orthotopic liver transplantation: Technically very difficult, life-sustaining graft, and clinically relevant model of spontaneous graft acceptance.

References

    1. Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 174: 542–550 - PubMed
    1. Akiyoshi T, Hirohashi T, Alessandrini A, Chase CM, Farkash EA, Neal Smith R, Madsen JC, Russell PS, Colvin RB 2012. Role of complement and NK cells in antibody mediated rejection. Hum Immunol 73: 1226–1232 - PMC - PubMed
    1. Alegre ML, Fallarino F 2006. Mechanisms of CTLA-4Ig in tolerance induction. Curr Pharm Des 12: 149–160 - PubMed
    1. Alegre ML, Frauwirth KA, Thompson CB 2001. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1: 220–228 - PubMed
    1. Aoyagi T, Yamashita K, Suzuki T, Uno M, Goto R, Taniguchi M, Miura T, Okimura K, Itoh T, Shimizu A, et al. 2009. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: Induction and maintenance therapy. Am J Transplant 9: 1732–1741 - PubMed

Publication types